Author Affiliation: Division of Thoracic Surgery, Department of Surgery, University of Maryland School of Medicine, Baltimore (email@example.com).
Dantoc et al1 performed a meta-analysis of 16 studies that included 1212 patients undergoing esophagectomy for esophageal cancer. The authors found that the median number of lymph nodes removed was higher in the group undergoing minimally invasive esophagectomy (MIE) compared with the open group (16 vs 10 [P = .04]), but they found no difference in 30-day or overall survival. From this analysis, the authors concluded that MIE is a viable alternative to open esophagectomy with equivalent oncological outcomes.
Battafarano RJ. The Goal of Esophagogastrectomy for Patients With Esophageal Cancer: Minimally Invasive or Maximally Effective? Comment on “Evidence to Support the Use of Minimally Invasive Esophagectomy for Esophageal Cancer”. Arch Surg. 2012;147(8):776–777. doi:10.1001/archsurg.2012.1748
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.